Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 63

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment

Gasco, Valentina, Cambria, Valeria, Bioletto, Fabio, Ghigo, Ezio, Grottoli, Silvia·2021·Frontiers in Endocrinology
DOI 10.3389/fendo.2021.634415
Open this paper in CoChat — free account

Abstract

Traumatic brain injury (TBI)-related hypopituitarism has been recognized as a clinical entity for more than a century, with the first case being reported in 1918. However, during the 20 th century hypopituitarism was considered only a rare sequela of TBI. Since 2000 several studies strongly suggest that TBI-mediated pituitary hormones deficiency may be more frequent than previously thought. Growth hormone deficiency (GHD) is the most common abnormality, followed by hypogonadism, hypothyroidism, hypocortisolism, and diabetes insipidus. The pathophysiological mechanisms underlying pituitary damage in TBI patients include a primary injury that may lead to the direct trauma of the hypothalamus or pituitary gland; on the other hand, secondary injuries are mainly related to an interplay of a complex and ongoing cascade of specific molecular/biochemical events. The available data describe the importance of GHD after TBI and its influence in promoting neurocognitive and behavioral deficits. The poor outcomes that are seen with long standing GHD in post TBI patients could be improved by GH treatment, but to date literature data on the possible beneficial effects of GH replacement therapy in post-TBI GHD patients are currently scarce and fragmented. More studies are needed to further characterize this clinical syndrome with the purpose of establishing appropriate standards of care. The purpose of this review is to summarize the current state of knowledge about post-traumatic GH deficiency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2021.634415

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 124

  1. Taylor, 2017, Morbidity and Mortality Weekly Report Traumatic Brain Injury-Related Emergency Department Visits, Hospitalizations, and Deaths-United States, 2007 and 2013, MMWR Surveill Summ, 66, 1, 10.15585/mmwr.ss6609a1 · DOI · Paper page
  2. Zaloshnja, 2008, Prevalence of Long-Term Disability From Traumatic Brain Injury in the Civilian Population of the United States, 2005, J Head Trauma Rehabil, 23, 394, 10.1097/01.HTR.0000341435.52004.ac · DOI · Paper page
  3. Lieberman, 2001, Prevalence of Neuroendocrine Dysfunction in Patients Recovering from Traumatic Brain Injury, J Clin Endocrinol Metab, 86, 10.1210/jcem.86.6.7592 · DOI · Paper page
  4. Van Der Eerden, 2010, Should anterior pituitary function be tested during follow-up of all patients presenting at the emergency department because of traumatic brain injury, Eur J Endocrinol, 162, 19, 10.1530/EJE-09-0436 · DOI · Paper page
  5. Moreau, 2012, Lasting pituitary hormone deficiency after traumatic brain injury, J Neurotrauma, 29, 10.1089/neu.2011.2048 · DOI · Paper page
  6. Emelifeonwu, 2020, Prevalence of Anterior Pituitary Dysfunction Twelve Months or More following Traumatic Brain Injury in Adults: A Systematic Review and Meta-Analysis, J Neurotrauma, 37, 10.1089/neu.2018.6349 · DOI · Paper page
  7. Max, 1991, Head injuries: costs and consequences, J Head Trauma Rehabil, 6, 76, 10.1097/00001199-199106000-00010 · DOI
  8. Thompson, 2012, Utilization and costs of health care after geriatric traumatic brain injury, J Neurotrauma, 29, 10.1089/neu.2011.2284 · DOI
  9. Cyran, 1918, Hypophysenschadigung durch Schadelbasisfraktur, Dtsch Med Wochenschr, 44, 1261
  10. Cuesta, 2016, Symptoms of gonadal dysfunction are more predictive of hypopituitarism than nonspecific symptoms in screening for pituitary dysfunction following moderate or severe traumatic brain injury, Clin Endocrinol (Oxf), 84, 10.1111/cen.12874 · DOI · Paper page
  11. Klose, 2007, Posttraumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12 months after injury, J Clin Endocrinol Metab, 92, 10.1210/jc.2007-0901 · DOI · Paper page
  12. Nourollahi, 2014, Quality-of-life in patients with post-traumatic hypopituitarism, Brain Inj, 28, 10.3109/02699052.2014.917201 · DOI
  13. Silva, 2015, Predictors of Hypopituitarism in Patients with Traumatic Brain Injury, J Neurotrauma, 32, 10.1089/neu.2015.3998 · DOI
  14. Ulfarsson, 2013, Pituitary function and functional outcome in adults after severe traumatic brain injury: The long-term perspective, J Neurotrauma, 30, 10.1089/neu.2012.2494 · DOI
  15. Zgaljardic, 2011, Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing, Clin Endocrinol (Oxf), 74, 10.1111/j.1365-2265.2010.03935.x · DOI
  16. Aimaretti, 2005, Residual pituitary function after brain injury-induced hypopituitarism: A prospective 12-month study, J Clin Endocrinol Metab, 90, 10.1210/jc.2005-0504 · DOI · Paper page
  17. Kleindienst, 2009, Neuroendocrine function following traumatic brain injury and subsequent intensive care treatment: A prospective longitudinal evaluation, J Neurotrauma, 26, 10.1089/neu.2008.0601 · DOI · Paper page
  18. Berg, 2010, Prevalence of anterior pituitary dysfunction in patients following traumatic brain injury in a german multi-centre screening program, Exp Clin Endocrinol Diabetes, 118, 10.1055/s-0029-1225611 · DOI
  19. Bondanelli, 2004, Occurrence of pituitary dysfunction following traumatic brain injury, J Neurotrauma, 21, 10.1089/0897715041269713 · DOI · Paper page
  20. Hari Kumar, 2016, Prevalence of hypothalamo pituitary dysfunction in patients of traumatic brain injury, Indian J Endocrinol Metab, 20, 10.4103/2230-8210.192917 · DOI
  21. Nemes, 2015, Predictors of post-traumatic pituitary failure during long-term follow-up, Hormones, 14, 10.14310/horm.2002.1564 · DOI · Paper page
  22. Wachter, 2009, Pituitary insufficiency after traumatic brain injury, J Clin Neurosci, 16, 10.1016/j.jocn.2008.01.009 · DOI · Paper page
  23. Klose, 2014, Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: Results from the danish national study on posttraumatic hypopituitarism, J Clin Endocrinol Metab, 99, 10.1210/jc.2013-2397 · DOI · Paper page
  24. Park, 2010, Anterior pituitary dysfunction in moderate-to-severe chronic traumatic brain injury patients and the influence on functional outcome, Brain Inj, 24, 10.3109/02699052.2010.506863 · DOI · Paper page
  25. Teasdale, 1974, Assessment of coma and impaired consciousness. A practical scale, Lancet, 2, 10.1016/S0140-6736(74)91639-0 · DOI · Paper page
  26. Kaur, 2018, Recent Advances in Pathophysiology of Traumatic Brain Injury, Curr Neuropharmacol, 16, 10.2174/1570159X15666170613083606 · DOI · Paper page
  27. Grandhi, 2014, Surgical management of traumatic brain injury: a review of guidelines, pathophysiology, neurophysiology, outcomes, and controversies, J Neurosurg Sci, 58
  28. Daniel, 1958, Extent of the infarct in the anterior lobe of the human pituitary gland after stalk section, Lancet, 1, 10.1016/S0140-6736(58)91852-X · DOI
  29. Bullock, 1998, Factors affecting excitatory amino acid release following severe human head injury, J Neurosurg, 89, 10.3171/foc.1998.5.2.1 · DOI
  30. Xuereb, 1954, The arterial supply and venous drainage of the human hypophysis cerebri, Q J Exp Physiol Cognit Med Sci, 39, 199, 10.1113/expphysiol.1954.sp001072 · DOI
  31. Xuereb BG, 1954, The hypophyseal portal system of vessels in man, Q J Exp Physiol Cognit Med Sci, 39, 10.1113/expphysiol.1954.sp001073 · DOI
  32. Gorczyca, 1987, Arterial supply of the human anterior pituitary gland, Neurosurgery, 20, 10.1227/00006123-198703000-00003 · DOI · Paper page
  33. Famini, 2014, Pituitary Apoplexy, 175, 10.1007/978-1-62703-697-9_17 · DOI
  34. Horvath, 1988, Fine Structural Cytology of the Adenohypophysis in Rat and Man, J Electron Microsc Tech, 8, 10.1002/jemt.1060080410 · DOI
  35. Tanriverdi, 2008, Antipituitary antibodies after traumatic brain injury: Is head trauma-induced pituitary dysfunction associated with autoimmunity, Eur J Endocrinol, 159, 7, 10.1530/EJE-08-0050 · DOI · Paper page
  36. Diaz-Arrastia, 2003, Increased Risk of Late Posttraumatic Seizures Associated With Inheritance of APOE 4 Allele, Arch Neurol, 60, 10.1001/archneur.60.6.818 · DOI
  37. Sorbi, 1995, ApoE as a prognostic factor for post-traumatic coma, Nat Med, 1, 852, 10.1038/nm0995-852 · DOI
  38. Crawford, 2002, APOE genotype influences acquisition and recall following traumatic brain injury, Neurology, 58, 10.1212/WNL.58.7.1115 · DOI
  39. Tanriverdi, 2008, Apolipoprotein E3/E3 genotype decreases the risk of pituitary dysfunction after traumatic brain injury due to various causes: Preliminary data, J Neurotrauma, 25, 10.1089/neu.2007.0456 · DOI · Paper page
  40. Ceballos, 1966, Pituitary changes in head trauma (analysis of 102 consecutive cases of head injury), Ala J Med Sci, 3
  41. Kornblum, 1969, Pituitary lesions in craniocerebral injuries, Arch Pathol, 88
  42. Beauchamp, 1999, Imaging of Acute Cerebral Ischemia, Radiology, 212, 10.1148/radiology.212.2.r99au16307 · DOI
  43. Warach, 1995, Acute Human Stroke Studied by Whole Brain Echo Planar Dfision-weighted Magnetic Resonance Imaging, Ann Neurol, 37, 10.1002/ana.410370214 · DOI · Paper page
  44. Kuhl, 2005, Acute and subacute ischemic stroke at high-field-strength (3.0-T) diffusion-weighted MR imaging: Intraindividual comparative study, Radiology, 234, 10.1148/radiol.2342031323 · DOI
  45. Caputo, 2019, Clinical picture and the treatment of TBI-induced hypopituitarism, Pituitary, 22, 10.1007/s11102-019-00956-w · DOI · Paper page
  46. Agha, 2004, Posterior pituitary dysfunction after traumatic brain injury, J Clin Endocrinol Metab, 89, 10.1210/jc.2004-1058 · DOI · Paper page
  47. Agha, 2005, The natural history of post-traumatic hypopituitarism: Implications for assessment and treatment, Am J Med, 118, 1416.e1, 10.1016/j.amjmed.2005.02.042 · DOI · Paper page
  48. Gray, 2019, Hypopituitarism After Traumatic Brain Injury, Cureus, 11, 10.7759/cureus.4163 · DOI
  49. Prodam, 2012, Quality of life, mood disturbances and psychological parameters in adult patients with GH deficiency, Panminerva Med, 54
  50. Gilis-Januszewska, 2020, Traumatic brain injuries induced pituitary dysfunction: A call for algorithms, Endocr Connect, 9, 10.1530/EC-20-0117 · DOI · Paper page
  51. Cheng, 2003, Insulin-like growth factor 1 is essential for normal dendritic growth, J Neurosci Res, 73, 1, 10.1002/jnr.10634 · DOI
  52. Kelly, 2006, Neurobehavioral and quality of life changes associated with growth hormone insufficiency after complicated mild, moderate, or severe traumatic brain injury, J Neurotrauma, 23, 10.1089/neu.2006.23.928 · DOI · Paper page
  53. Kgosidialwa, 2019, Growth hormone deficiency following traumatic brain injury, Int J Mol Sci, 20, 3323, 10.3390/ijms20133323 · DOI · Paper page
  54. Park, 2016, Voxel-based statistical analysis of brain metabolism in patients with growth hormone deficiency after traumatic brain injury, Brain Inj, 30, 10.3109/02699052.2015.1127997 · DOI
  55. Pavlovic, 2010, Chronic cognitive sequelae after traumatic brain injury are not related to growth hormone deficiency in adults, Eur J Neurol, 17, 696, 10.1111/j.1468-1331.2009.02910.x · DOI
  56. Glynn, 2019, The frequency and the diagnosis of pituitary dysfunction after traumatic brain injury, Pituitary, 22, 10.1007/s11102-019-00938-y · DOI · Paper page
  57. Thaler, 1998, The Low Dose (1-μg) Adrenocorticotropin Stimulation Test in the Evaluation of Patients with Suspected Central Adrenal Insufficiency, J Clin Endocrinol Metab, 83, 10.1210/jc.83.8.2726 · DOI
  58. Ceccato, 2018, Central adrenal insufficiency: Open issues regarding diagnosis and glucocorticoid treatment, Clin Chem Lab Med, 57, 10.1515/cclm-2018-0824 · DOI
  59. Vespa, 1999, Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring, J Neurosurg, 91, 10.3171/jns.1999.91.5.0750 · DOI · Paper page
  60. Corneli, 2005, The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index, Eur J Endocrinol, 153, 10.1530/eje.1.01967 · DOI · Paper page
  61. Gómez, 2002, Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults, Clin Endocrinol (Oxf), 56, 10.1046/j.1365-2265.2002.01472.x · DOI · Paper page
  62. Kelestimur, 2006, Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test, Clin Endocrinol (Oxf), 64, 10.1111/j.1365-2265.2006.02525.x · DOI · Paper page
  63. Gasco, 2020, The cut-off limits of GH response to insulin tolerance test related to body mass index for the diagnosis of adult GH deficiency
  64. Devesa, 2010, Growth hormone revisited, Med Clin, 135, 10.1016/j.medcli.2009.10.017 · DOI
  65. Costoya, 1999, Activation of growth hormone receptor delivers an antiapoptotic signal: Evidence for a role of Akt in this pathway, Endocrinology, 140, 10.1210/endo.140.12.7209 · DOI
  66. Sanders, 2009, Signaling mechanisms mediating local GH action in the neural retina of the chick embryo, Gen Comp Endocrinol, 163, 10.1016/j.ygcen.2009.01.005 · DOI
  67. McLenachan, 2009, Growth hormone promotes proliferation of adult neurosphere cultures, Growth Horm IGF Res, 19, 10.1016/j.ghir.2008.09.003 · DOI
  68. Åberg, 2009, Peripheral administration of GH induces cell proliferation in the brain of adult hypophysectomized rats, J Endocrinol, 201, 10.1677/JOE-08-0495 · DOI
  69. Scheepens, 1999, Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury, Mol Brain Res, 68, 88, 10.1016/s0169-328x(99)00051-0 · DOI
  70. Madathil, 2010, Temporal and regional changes in IGF-1/IGF-1R signaling in the mouse brain after traumatic brain injury, J Neurotrauma, 27, 95, 10.1089/neu.2009.1002 · DOI
  71. Walter, 1997, Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine/paracrine actions of IGF-I within wounds of the rat brain, Endocrinology, 138, 10.1210/endo.138.7.5284 · DOI
  72. Christophidis, 2009, Growth hormone receptor immunoreactivity is increased in the subventricular zone of juvenile rat brain after focal ischemia: A potential role for growth hormone in injury-induced neurogenesis, Growth Horm IGF Res, 19, 497, 10.1016/j.ghir.2009.05.001 · DOI
  73. Li, 2011, Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats, Neuroscience, 196, 10.1016/j.neuroscience.2011.08.029 · DOI
  74. Pathipati, 2011, Growth hormone and prolactin regulate human neural stem cell regenerative activity, Neuroscience, 190, 10.1016/j.neuroscience.2011.05.029 · DOI
  75. Devesa, 2011, Growth hormone (GH) treatment may cooperate with locally-produced GH in increasing the proliferative response of hippocampal progenitors to kainate-induced injury, Brain Inj, 25, 10.3109/02699052.2011.559611 · DOI
  76. Åberg, 2010, Peripheral growth hormone induces cell proliferation in the intact adult rat brain, Growth Horm IGF Res, 20, 10.1016/j.ghir.2009.12.003 · DOI
  77. Devesa, 2011, Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study, Ther Clin Risk Manage, 7, 199, 10.2147/TCRM.S21403 · DOI
  78. Möderscheim, 2007, Distinct neuronal growth hormone receptor ligand specificity in the rat brain, Brain Res, 1137, 29, 10.1016/j.brainres.2006.12.040 · DOI
  79. Byts, 2008, Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin, Cell Death Differ, 15, 10.1038/cdd.2008.1 · DOI
  80. Silva, 2003, Growth Hormone Prevents Human Immunodeficiency Virus-Induced Neuronal p53 Expression, Ann Neurol, 54, 10.1002/ana.10729 · DOI
  81. Van Marle, 2005, Aberrant cortical neurogenesis in a pediatric neuroAIDS model: Neurotrophic effects of growth hormone, AIDS, 19, 10.1097/01.aids.0000189854.06194.87 · DOI
  82. Devesa, 2011, Effects of growth hormone on the central and peripheral neural repair
  83. Lichtenwalner, 2006, Adult-onset deficiency in growth hormone and insulin-like growth factor-I decreases survival of dentate granule neurons: Insights into the regulation of adult hippocampal neurogenesis, J Neurosci Res, 83, 199, 10.1002/jnr.20719 · DOI
  84. Sun, 2007, Adult neurogenesis in the hippocampus of long-lived mice during aging, J Gerontol Ser A Biol Sci Med Sci, 62, 10.1093/gerona/62.2.117 · DOI
  85. Ajo, 2003, Growth hormone action on proliferation and differentiation of cerebral cortical cells from fetal rat, Endocrinology, 144, 10.1210/en.2002-220667 · DOI
  86. Lyuh, 2007, Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells, Growth Horm IGF Res, 17, 10.1016/j.ghir.2007.03.002 · DOI
  87. Russo, 2005, The insulin-like growth factor system and its pleiotropic functions in brain, Endocr Rev, 26, 10.1210/er.2004-0024 · DOI · Paper page
  88. Popken, 2005, Brain development, Adv Exp Med Biol, 567, 187, 10.1007/0-387-26274-1_8 · DOI
  89. D’Ercole, 2008, Minireview: Expanding the mind: Insulin-like growth factor I and brain development, Endocrinology, 149, 10.1210/en.2008-0920 · DOI
  90. Torres-Aleman, 2010, Toward a comprehensive neurobiology of IGF-I, Dev Neurobiol, 70, 10.1002/dneu.20778 · DOI
  91. Yan, 2011, Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence, J Endocrinol, 211, 27, 10.1530/JOE-11-0200 · DOI
  92. Calzà, 2003, Neural stem cells and cholinergic neurons: Regulation by immunolesion and treatment with mitogens, retinoic acid, and nerve growth factor, Proc Natl Acad Sci U S A, 100, 10.1073/pnas.1132092100 · DOI
  93. Türeyen, 2005, EGF and FGF-2 infusion increases post-ischemic neural progenitor cell proliferation in the adult rat brain, Neurosurgery, 57, 10.1227/01.neu.0000186040.96929.8a · DOI
  94. Yamauchi, 1998, Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression, Endocr J, 45, S27, 10.1507/endocrj.45.suppl_s27 · DOI
  95. Pan, 2011, Epidermal growth factor receptor signalling mediates growth hormone-induced growth of chondrocytes from sex hormone-inhibited adolescent rats, Clin Exp Pharmacol Physiol, 38, 10.1111/j.1440-1681.2011.05547.x · DOI
  96. Byts, 2009, Erythropoietin: a multimodal neuroprotective agent, Exp Transl Stroke Med, 1, 4, 10.1186/2040-7378-1-4 · DOI
  97. Chen, 2007, Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation, J Biol Chem, 282, 10.1074/jbc.M701988200 · DOI
  98. Tsai, 2006, A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery, J Neurosci, 26, 10.1523/JNEUROSCI.4480-05.2006 · DOI · Paper page
  99. Zhang, 2010, Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat, PloS One, 5, 10.1371/journal.pone.0011016 · DOI
  100. Sohmiya, 2001, Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult gh deficiency, Clin Endocrinol (Oxf), 55, 10.1046/j.1365-2265.2001.01417.x · DOI
  101. Devesa, 2016, Multiple effects of growth hormone in the body: Is it really the hormone for growth, Clin Med Insights Endocrinol Diabetes, 9, 47, 10.4137/CMED.S38201 · DOI
  102. Lu, 2019, Targeting growth hormone function: strategies and therapeutic applications, Signal Transduct Target Ther, 4, 3, 10.1038/s41392-019-0036-y · DOI
  103. Gasco, 2017, Management of GH treatment in adult GH deficiency, Best Pract Res Clin Endocrinol Metab, 31, 13, 10.1016/j.beem.2017.03.001 · DOI
  104. Leonhardt, 2018, Low Prevalence of Isolated Growth Hormone Deficiency in Patients After Brain Injury: Results From a Phase II Pilot Study, Front Endocrinol (Lausanne), 9, 10.3389/fendo.2018.00723 · DOI
  105. Dubiel, 2018, Phase 2 randomized, placebo-controlled clinical trial of recombinant human growth hormone (rhGH) during rehabilitation from traumatic brain injury, Front Endocrinol (Lausanne), 9, 10.3389/fendo.2018.00520 · DOI
  106. Gadelha, 2014, Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): A randomised, phase 3 trial, Lancet Diabetes Endocrinol, 2, 10.1016/S2213-8587(14)70169-X · DOI · Paper page
  107. Colao, 2009, A reappraisal of diagnosing GH deficiency in adults: Role of gender, age, waist circumference, and body mass index, J Clin Endocrinol Metab, 94, 10.1210/jc.2009-1134 · DOI
  108. Zhai, 1994, Characterization of growth hormone binding sites in rat brain, Acta Pædiatrica, 83, 10.1111/j.1651-2227.1994.tb13433.x · DOI
  109. Lai, 1993, Age-related reduction of human growth hormone-binding sites in the human brain, Brain Res, 621, 10.1016/0006-8993(93)90114-3 · DOI
  110. Nyberg, 2000, Growth hormone in the brain: Characteristics of specific brain targets for the hormone and their functional significance, Front Neuroendocrinol, 21, 10.1006/frne.2000.0200 · DOI
  111. Ho, 2007, Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: A statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, J Eur J Endocrinol, 157, 695, 10.1530/EJE-07-0631 · DOI · Paper page
  112. Maruff, 2005, Cognitive function in growth hormone deficiency and growth hormone replacement, Hormone Res Horm Res, 64, 10.1159/000089325 · DOI
  113. Van Dam, 2006, Somatropin therapy and cognitive function in adults with growth hormone deficiency: A critical review, Treat Endocrinol, 5, 10.2165/00024677-200605030-00004 · DOI
  114. Nieves-Martinez, 2010, Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation, J Endocrinol, 204, 10.1677/JOE-09-0323 · DOI
  115. Svensson, 2004, Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy, J Clin Endocrinol Metab, 89, 10.1210/jc.2003-031601 · DOI
  116. Maison, 2004, Impact of Growth Hormone (GH) Treatment on Cardiovascular Risk Factors in GH-Deficient Adults: A Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials, J Clin Endocrinol Metab, 89, 10.1210/jc.2003-030840 · DOI · Paper page
  117. Giustina, 2008, Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults, J Endocrinol Invest, 31, 10.1007/BF03349263 · DOI
  118. Tanriverdi, 2010, Hypopituitarism due to sports related head trauma and the effects of growth hormone replacement in retired amateur boxers, Pituitary, 13, 10.1007/s11102-009-0204-0 · DOI · Paper page
  119. Bhagia, 2010, Effect of recombinant growth hormone replacement in a growth hormone deficient subject recovering from mild traumatic brain injury: A case report, Brain Inj, 24, 10.3109/02699051003601705 · DOI · Paper page
  120. Wüster, 2001, The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density, J Bone Miner Res, 16, 398, 10.1359/jbmr.2001.16.2.398 · DOI · Paper page
  121. O’Halloran, 1993, Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency, J Clin Endocrinol Metab, 76, 10.1210/jcem.76.5.8496328 · DOI
  122. Wallymahmed, 1999, The quality of life of adults with growth hormone deficiency: Comparison with diabetic patients and control subjects, Clin Endocrinol (Oxf), 51, 10.1046/j.1365-2265.1999.00802.x · DOI
  123. Badia, 1998, One-year follow-up of quality of life in adults with untreated growth hormone deficiency, Clin Endocrinol (Oxf), 49, 10.1046/j.1365-2265.1998.00634.x · DOI
  124. Appelman-Dijkstra, 2013, Long-term effects of recombinant human GH replacement in adults with GH deficiency: A systematic review, Eur J Endocrinol, 169, R1, 10.1530/EJE-12-1088 · DOI

Cited by

See all 63

Metadata

Authors
Gasco, V., Cambria, V., Bioletto, F., Ghigo, E., & Grottoli, S.
Venue
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Published
2021-03-15
Volume
12
ISSN
1664-2392
DOI
10.3389/fendo.2021.634415
Cited by
63
References
55
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.